August is supposed to be the quiet month. Somebody ought to tell the courts of Europe. In recent weeks, the same heart failure drug has had its SPC upheld in two jurisdictions on two quite different grounds of attack, the UPC has declined to wait for a French court, and a Dutch pharmacy has found where the compounding exemption stops.Entresto twice over: UK and Greece arrive at the same placeIn